Philipp Dohnke

Partner Corporate and M&A, Intellectual property

Primary practice

Corporate and M&A, Intellectual property

25/09/2021 Philipp Dohnke | Freshfields Bruckhaus Deringer About Philipp Dohnke

Philipp is a member of our intellectual property and information technology team.

Since joining the firm, he has worked across many industries with a particular focus on life science and technologies. Philipp has broad expertise in complex, high-profile transactions, including large carve-out and asset deal projects. In addition, Philipp is experienced in drafting and negotiating complex commercial contracts.

He speaks German and English.

Recent work

Apax and Warburg Pincus on their €5,1bn acquisition of T-Mobile Netherlands
Osram on the cave-out and sale of its Digital Systems business in North America to Acuity
Thermo Fisher on its €725m acquisition of the viral vector manufacturing business of Novasep (Belgium)
AstraZeneca on its $39bn acquisition of Alexion Pharmaceuticals
Charterhouse / Serb on the $800m acquisition of the BTG Specialty Pharmaceuticals business from Boston Scientific Corporation
Novartis on its $5.2bn acquisition of pharmaceutical product Xiidra from Takeda/Shire
Merck on its €3.4bn carve-out und sale of its consumer health business to Procter & Gamble
Boehringer Ingelheim on its €18bn business swap with Sanofi (Consumer Healthcare against Animal Health)
Boehringer Ingelheim on its sale of rights in the pharmaceutical product Buscopan in Brazil to Hypera
AstraZeneca / MedImmune on the acquisition of Definiens AG
BioNTech on license deals and other collaborations in the field of mRNA products / individualized medicines (including with Pfizer, Genentech, Sanofi, Eli Lilly, Bayer Animal Health and Genmab)
Advent International on the $1.9bn acquisition of Sanofi's generics business (Zentiva) and on the add-on acquisition of Alvogen's CEE business
Bridgepoint on the acquisition of Pharmazell (manufacturer of active pharmaceutical ingredients)
BC Partners on the €2.6bn acquisition of CeramTec
BC Partners on the acquisition of a majority stake in the Greek generics company Pharmathen
Charterhouse / Cooper on the acquisition of a consumer health product portfolio from Sanofi
Charterhouse / Serb on the acquisition of rights in a pharmaceutical product from a US biotech company
CVC on the acquisition of a 50% stake in the pharmaceutical excipient manufacturer DFE Pharma from Fonterra (Joint Venture with FrieslandCampina)
Qatar Investment Authority on an investment in the German biotech company CureVac
Airbus on a joint venture with Bombardier regarding the aircraft program "C Series" (now "A220") and on the subsequent exit of Bombardier from the joint venture
ABB on the carve-out and sale of its cable business to NKT
Cinven/Hotelbeds on the acquisition of the Global Travel Distribution business from Kuoni
Continental on the carve-out of its powertrain business ("Vitesco Technologies")
Deutsche Bank on the carve-out and listing of its Asset Management business ("DWS")
H.I.G. on the carve-out and acquisition of the European polyutherane "system house" business from Covestro
Hellman & Friedman on its €2.9bn acquisition of the internet platforms AutoScout24, FinanceScout24 und Finanzcheck

Qualifications

Education

Bucerius Law School, Hamburg, Germany, and Université25/09/2021 Philipp Dohnkede Paris| FreshfieldsI (Panthéon-Bruckhaus DeringerSorbonne), France (law)
Bucerius Law School, Hamburg, Germany (doctorate in law)
Traineeship (Referendariat) at the Higher Regional Court of Hamburg, Germany

Professional memberships

German Association for the Protection of Intellectual Property

Contact Philipp [email protected]

Hamburg Hohe Bleichen 7 20354 Hamburg T +49 40 36 90 60 F +49 40 36 90 61 55

25/09/2021 Philipp Dohnke | Freshfields Bruckhaus Deringer